Overview
- 2 public-safe observations are available for this inspection.
- 2 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
27 Feb 2012
21 CFR 312.50
Ensuring compliance with plan and protocol
Cited by Lequita M Mayhew, Bradley J Maunder
27 Feb 2012
21 CFR 812.43(c)(4)(i)
No investigation agreement statement of commitment
Cited by Lequita M Mayhew, Bradley J Maunder
Inspected site
APAstellas Pharma Global Development, Inc.Northbrook, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 312.50 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 812.43(c)(4)(i) | Cited across public-safe Form 483 observations | 1x |
Full 483 report
Get the verbatim text of all 2 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere